PATHWAY PROFILING ANTIBODIES & REAGENTS

     
Products
Product : Antibody >> Neurobiology , New Antibodies >> CLAC-P (NC2-1 region)
      
 

Polyclonal Antibody to CLAC-P (NC2-1 region)

 
Cat. No.DescriptionFormatUnitPrice(USD)QuantityBulk Quotation
IMG-4153
CLAC-P (NC2-1 region)Purified
0.1 mg
--
 
Catalog No: IMG-4153
Contents: 0.1 mg (1 mg/ml) in PBS containing 0.02% sodium azide.
Isotype: Rabbit IgG
Clone: N/A
Purification: Protein G purified
Species: Mouse, Human
Host: Rabbit
Application: Western blot analysis: 1:500
Storage: Maintain at +2-8°C for 3 months or at -20°C for longer periods. Stable for 1 year. Avoid repeated freeze-thaw cycles.
 

Background
Antibodies against senile plaque (SP) amyloid obtained a clone 9D2, which labeled amyloid fibrils in SPs and reacted with approximately 50/100 kDa polypeptides in Alzheimer's disease (AD) brains. The 9D2 antigen was identified as CLAC (collagen-like Alzheimer amyloid plaque component), and its precursor as CLAC-P/collagen type XXV. Both secreted and membrane-tethered forms of CLAC-P/collagen type XXV specifically bound to fibrillized Abeta, implicating these proteins in beta-amyloidogenesis and neuronal degeneration in AD.

Antigen
Peptide corresponding to amino acids 171-183 [NHGFLSADQQLIK] of the NC2-1 region of human and mouse CLAC-P.

Application Notes
Detects bands of 50, 70 and 100 kDa in SPs of AD brain, but not in diffuse plaques of non-demented aged individuals, diffuse deposits in sub-cortical structures and cerebellum in AD nor in cerebral amyloid angiopathy.

Genebank Info (Protein)
NP_942014

 
CLAC-P (NC2-1 region) Antibody

Western blot analysis of CLAC-P, using Img-4153 and IMG-4154 at 1:500 dilution on 100 ug of formic acid extracts of Alzheimer diseased brain.

-

Reference
1. Hashimoto,T. et. al. EMBO J. 21 (7), 1524-1534 (2002).


Research purposes only. Not for diagnostic or in vivo use. This product is guaranteed to perform as indicated on the datasheet for one year from the date of purchase.


Products

Services

Resources

Purchasing

Company

  • What's New
  • Reporter Cell Lines
  • Screening Services
  • Interactive Pathways